472
Views
6
CrossRef citations to date
0
Altmetric
Review

Beyond dry eye: how co-morbidities influence disease phenotype in dry eye disease

, &
Pages 177-185 | Received 06 Dec 2020, Accepted 27 Jul 2021, Published online: 08 Aug 2021

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15(3):276–283.
  • Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15(3):334–365.
  • Schaumberg DA, Dana R, Buring JE, et al. Prevalence of dry eye disease among US men: estimates from the physicians’ health studies. Arch Ophthalmol. 2009;127(6):763–768.
  • Schaumberg DA, Sullivan DA, Buring JE, et al. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318–326.
  • Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15(3):438–510.
  • Baudouin C. [A new approach for better comprehension of diseases of the ocular surface]. J Fr Ophtalmol. 2007;30(3):239–246.
  • Dartt DA, Willcox MD. Complexity of the tear film: importance in homeostasis and dysfunction during disease. Exp Eye Res. 2013;117:1–3.
  • Belmonte C, Nichols JJ, Cox SM, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15(3):404–437.
  • Galor A, Moein HR, Lee C, et al. Neuropathic pain and dry eye. Ocul Surf. 2018;16(1):31–44.
  • Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118(9):1264–1268.
  • Lee AJ, Lee J, Saw SM, et al. Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. Br J Ophthalmol. 2002;86(12):1347–1351.
  • Galor A, Feuer W, Lee DJ, et al. Prevalence and risk factors of dry eye syndrome in a United States veterans affairs population. Am J Ophthalmol. 2011;152(3):377–84 e2.
  • Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–468.
  • Martinez JD, Galor A, Ramos-Betancourt N, et al. Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City. Clin Ophthalmol. 2016;10:1335–1342.
  • Uchino M, Nishiwaki Y, Michikawa T, et al. Prevalence and risk factors of dry eye disease in Japan: koumi study. Ophthalmology. 2011;118(12):2361–2367.
  • Vehof J, Kozareva D, Hysi PG, et al. Prevalence and risk factors of dry eye disease in a British female cohort. Br J Ophthalmol. 2014;98(12):1712–1717.
  • Dana R, Bradley JL, Guerin A, et al. Comorbidities and prescribed medications in patients with or without dry eye disease: a population-based study. Am J Ophthalmol. 2019;198:181–192.
  • Wang TJ, Wang IJ, Hu CC, et al. Comorbidities of dry eye disease: a nationwide population-based study. Acta Ophthalmol. 2012;90(7):663–668.
  • Rischmueller M, Tieu J, Lester S. Primary Sjogren’s syndrome. Best Pract Res Clin Rheumatol. 2016;30(1):189–220.
  • Patel R, Shahane A. The epidemiology of Sjogren’s syndrome. Clin Epidemiol. 2014;6:247–255.
  • Shiboski CH, Shiboski SC, Seror R, et al. 2016 American college of rheumatology/european league against rheumatism classification criteria for primary Sjogren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35–45.
  • Ziaragkali S, Kotsalidou A, Trakos N. Dry eye disease in routine rheumatology practice. Mediterr J Rheumatol. 2018;29(3):127–139.
  • Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164(12):1275–1284.
  • Akpek EK, Klimava A, Thorne JE, et al. Evaluation of patients with dry eye for presence of underlying Sjogren syndrome. Cornea. 2009;28(5):493–497.
  • Bunya VY, Fernandez KB, Ying GS, et al. Survey of ophthalmologists regarding practice patterns for dry eye and sjogren syndrome. Eye Contact Lens. 2018;44(Suppl 2):S196–S201.
  • Liew MS, Zhang M, Kim E, et al. Prevalence and predictors of Sjogren’s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol. 2012;96(12):1498–1503.
  • Shimazaki J, Goto E, Ono M, et al. Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology. 1998;105(8):1485–1488.
  • Wang Y, Qin Q, Liu B, et al. Clinical analysis: aqueous-deficient and meibomian gland dysfunction in patients with primary Sjogren’s syndrome. Front Med (Lausanne). 2019;6:291.
  • Seeliger T, Prenzler NK, Gingele S, et al. Neuro-Sjogren: peripheral neuropathy with limb weakness in Sjogren’s syndrome. Front Immunol. 2019;10:1600.
  • Tuisku IS, Konttinen YT, Konttinen LM, et al. Alterations in corneal sensitivity and nerve morphology in patients with primary Sjogren’s syndrome. Exp Eye Res. 2008;86(6):879–885.
  • Villani E, Galimberti D, Viola F, et al. The cornea in Sjogren’s syndrome: an in vivo confocal study. Invest Ophthalmol Vis Sci. 2007;48(5):2017–2022.
  • Benitez del Castillo JM, Wasfy MA, Fernandez C, et al. An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci. 2004;45(9):3030–3035.
  • Yang AY, Chow J, Liu J. Corneal innervation and sensation: the eye and beyond. Yale J Biol Med. 2018;91(1):13–21.
  • Sebastian A, Szachowicz A, Wiland P. Classification criteria for secondary Sjogren’s syndrome. Current state of knowledge. Reumatologia. 2019;57(5):277–280.
  • Theander E, Jacobsson LT. Relationship of Sjogren’s syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am. 2008;34(4):935-47, viii-ix.
  • Ramos-Casals M, Brito-Zeron P, Font J. The overlap of Sjogren’s syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum. 2007;36(4):246–255.
  • Andonopoulos AP, Drosos AA, Skopouli FN, et al. Secondary Sjogren’s syndrome in rheumatoid arthritis. J Rheumatol. 1987;14(6):1098–1103.
  • Gilboe IM, Kvien TK, Uhlig T, et al. Sicca symptoms and secondary Sjogren’s syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis. 2001;60(12):1103–1109.
  • Avouac J, Sordet C, Depinay C, et al. Systemic sclerosis-associated Sjogren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006;54(7):2243–2249.
  • Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Sjogren’s syndrome in progressive systemic sclerosis. J Rheumatol. 1988;15(6):965–968.
  • Pasadhika S, Rosenbaum JT. Ocular Sarcoidosis. Clin Chest Med. 2015;36(4):669–683.
  • Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885–1889.
  • Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9(4):215–233.
  • Tuchocka-Piotrowska A, Puszczewicz M, Kolczewska A, et al. [Graft-versus-host disease as the cause of symptoms mimicking Sjogren’s syndrome]. Ann Acad Med Stetin. 2006;52(Suppl 2):89–93.
  • Arai S, Jagasia M, Storer B, et al. Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria. Blood. 2011;118(15):4242–4249.
  • Rapoport Y, Freeman T, Koyama T, et al. Validation of international chronic ocular graft-versus-host disease (GVHD) group diagnostic criteria as a chronic ocular GVHD-specific metric. Cornea. 2017;36(2):258–263.
  • Westeneng AC, Hettinga Y, Lokhorst H, et al. Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea. 2010;29(7):758–763.
  • Imanguli MM, Atkinson JC, Mitchell SA, et al. Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation. Biol Blood Marrow Transplant. 2010;16(10):1362–1369.
  • Yang WJ, Yang YN, Cao J, et al. Risk factors for dry eye syndrome: a retrospective case-control study. Optom Vis Sci. 2015;92(9):e199–205.
  • Koike K, Moriya K, Ishibashi K, et al. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci U S A. 1997;94(1):233–236.
  • Baumert TF, Berg T, Lim JK, et al. Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges. Gastroenterology. 2019;156(2):431–445.
  • Yamada M, Li AW, Wall JR. Thyroid-associated ophthalmopathy: clinical features, pathogenesis, and management. Crit Rev Clin Lab Sci. 2000;37(6):523–549.
  • Nowak M, Marek B, Kos-Kudla B. et al. Tear film profile in patients with active thyroid orbithopathy. Klin Oczna. 2005;107(7–9):479–482.
  • Heufelder AE. Pathogenesis of graves’ ophthalmopathy. Z Arztl Fortbild Qualitatssich. 1999;93(Suppl 1):35–39.
  • Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves’ ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121(3):284–290.
  • Razek AA, El-Hadidy EM, Moawad ME, et al. Assessment of lacrimal glands in thyroid eye disease with diffusion-weighted magnetic resonance imaging. Pol J Radiol. 2019;84:e142–e6.
  • Gilbard JP, Farris RL. Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol (Copenh). 1983;61(1):108–116.
  • Iskeleli G, Karakoc Y, Abdula A. Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol. 2008;52(4):323–326.
  • Rainer BM, Kang S, Chien AL. Rosacea: epidemiology, pathogenesis, and treatment. Dermatoendocrinol. 2017;9(1):e1361574.
  • Machalinska A, Zakrzewska A, Markowska A, et al. Morphological and functional evaluation of meibomian gland dysfunction in rosacea patients. Curr Eye Res. 2016;41(8):1029–1034.
  • Zengin N, Tol H, Gunduz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 1995;14(2):144–146.
  • Berk T, Scheinfeld N. Seborrheic dermatitis. P T. 2010;35(6):348–352.
  • Yasar E, Kemeriz F, Gurlevik U. Evaluation of dry eye disase and meibomian gland dysfunction with meibography in seborrheic dermatitis. Cont Lens Anterior Eye. 2019;42(6):675–678.
  • Villani E, Rabbiolo G, Nucci P. Ocular allergy as a risk factor for dry eye in adults and children. Curr Opin Allergy Clin Immunol. 2018;18(5):398–403.
  • Khurana AK, Moudgil SS, Parmar IP, et al. Tear film flow and stability in acute and chronic conjunctivitis. Acta Ophthalmol (Copenh). 1987;65(3):303–305.
  • Ibrahim OM, Matsumoto Y, Dogru M, et al. In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients. Ophthalmology. 2012;119(10):1961–1968.
  • Arita R, Itoh K, Maeda S, et al. Meibomian gland duct distortion in patients with perennial allergic conjunctivitis. Cornea. 2010;29(8):858–860.
  • Suzuki S, Goto E, Dogru M, et al. Tear film lipid layer alterations in allergic conjunctivitis. Cornea. 2006;25(3):277–280.
  • Valls-Sole J, Defazio G. Blepharospasm: update on epidemiology, clinical aspects, and pathophysiology. Front Neurol. 2016;7:45.
  • Lu R, Huang R, Li K, et al. The influence of benign essential blepharospasm on dry eye disease and ocular inflammation. Am J Ophthalmol. 2014;157(3):591-7 e1-2.
  • Ho RW, Fang PC, Chang CH, et al. A review of periocular botulinum neurotoxin on the tear film homeostasis and the ocular surface change. Toxins (Basel). 2019;11:2.
  • Ansari Z, Singh R, Alabiad C, et al. Prevalence, risk factors, and morbidity of eye lid laxity in a veteran population. Cornea. 2015;34(1):32–36.
  • Chhadva P, McClellan AL, Alabiad CR, et al. Impact of eyelid laxity on symptoms and signs of dry eye disease. Cornea. 2016;35(4):531–535.
  • Zhang X, Li Q, Zou H, et al. Assessing the severity of conjunctivochalasis in a senile population: a community-based epidemiology study in Shanghai, China. BMC Public Health. 2011;11:198.
  • Chhadva P, Alexander A, McClellan AL, et al. The impact of conjunctivochalasis on dry eye symptoms and signs. Invest Ophthalmol Vis Sci. 2015;56(5):2867–2871.
  • Wang Y, Dogru M, Matsumoto Y, et al. The impact of nasal conjunctivochalasis on tear functions and ocular surface findings. Am J Ophthalmol. 2007;144(6):930–937.
  • Li N, Wang T, Wang R, et al. Tear film instability and meibomian gland dysfunction correlate with the pterygium size and thickness pre- and postexcision in patients with pterygium. J Ophthalmol. 2019;2019:5935239.
  • Xu G, Liu B, Sun Y, et al. Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study. BMJ. 2018;362:k1497.
  • Zhang X, Zhao L, Deng S, et al. Dry eye syndrome in patients with diabetes mellitus: prevalence, etiology, and clinical characteristics. J Ophthalmol. 2016;2016:8201053.
  • Sacchetti M, Lambiase A. Diagnosis and management of neurotrophic keratitis. Clin Ophthalmol. 2014;8:571–579.
  • Zeng X, Lv Y, Gu Z, et al. The effects of diabetic duration on lacrimal functional unit in patients with type II diabetes. J Ophthalmol. 2019;2019:8127515.
  • Ziegler D, Papanas N, Zhivov A, et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. 2014;63(7):2454–2463.
  • Markoulli M, Flanagan J, Tummanapalli SS, et al. The impact of diabetes on corneal nerve morphology and ocular surface integrity. Ocul Surf. 2018;16(1):45–57.
  • Kinard KI, Smith AG, Singleton JR, et al. Chronic migraine is associated with reduced corneal nerve fiber density and symptoms of dry eye. Headache. 2015;55(4):543–549.
  • Farhangi M, Diel RJ, Buse DC, et al. Individuals with migraine have a different dry eye symptom profile than individuals without migraine. Br J Ophthalmol. 2020;104(2):260–264.
  • Koktekir BE, Celik G, Karalezli A, et al. Dry eyes and migraines: is there really a correlation? Cornea. 2012;31(12):1414–1416.
  • Aykut V, Elbay A, Esen F, et al. Patterns of altered corneal sensation in patients with chronic migraine. Eye Contact Lens. 2018;44(Suppl 2):S400–S3.
  • Diel RJ, Hwang J, Kroeger ZA, et al. Photophobia and sensations of dryness in patients with migraine occur independent of baseline tear volume and improve following botulinum toxin A injections. Br J Ophthalmol. 2019;103(8):1024–1029.
  • Vehof J, Sillevis Smitt-Kamminga N, Kozareva D, et al. Clinical characteristics of dry eye patients with chronic pain syndromes. Am J Ophthalmol. 2016;166:203–204.
  • Galor A, Covington D, Levitt AE, et al. Neuropathic ocular pain due to dry eye is associated with multiple comorbid chronic pain syndromes. J Pain. 2016;17(3):310–318.
  • Hasin DS, Sarvet A. L, Meyers J. L, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75(4):336–346.
  • Fernandez CA, Galor A, Arheart KL, et al. Dry eye syndrome, posttraumatic stress disorder, and depression in an older male veteran population. Invest Ophthalmol Vis Sci. 2013;54(5):3666–3672.
  • Labbe A, Wang YX, Jie Y, et al. Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study. Br J Ophthalmol. 2013;97(11):1399–1403.
  • Ulusoy MO, Isik-Ulusoy S, Kivanc SA. Evaluation of dry eye disease in newly diagnosed anxiety and depression patients using anterior segment optical coherence tomography. Eye Vis (Lond). 2019;6:25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.